Boill Healthcare Holdings Limited (stock code: 01246) released its Monthly Return for the period ended 30 November 2025. Authorized share capital remains at HKD120,000,000, comprising 480,000,000 ordinary shares at a par value of HKD0.25 each, unchanged from the previous month.

The total number of issued shares continues at 1,358,000,000, with no treasury shares. The company confirms compliance with the applicable 25% public float requirement. In addition, 135,800,000 shares are available for issue under a share option scheme adopted on 27 September 2023, with no new shares issued from the scheme during November 2025.